Podcast 12 Dec 2025Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach In this episode we sit down with Martin Beck, Senior Vice President and Head of the Inflammation Business Unit at Boehringer Ingelheim. December 12, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 5 Dec 2025Cracking Cancer’s Code: Transforming Research with Novel Cancer Models This week’s guest is Mark Lanasa of BeOne Medicines and we will discuss their novel cancer models and unique in-house R&D approach. December 5, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 28 Nov 2025Curing cancer: Daiichi Sankyo’s ambitious ADC approach In today’s episode, Dr. Markus Kosch, Head of the EU Oncology Business Division at Daiichi Sankyo will discuss the company’s approach November 28, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 21 Nov 2025How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenes Labiotech followed one biotech heading into their first BIO-Europe partnering conference: cancer therapeutics company DISCO Pharma. November 21, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 14 Nov 2025Meet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncology Labiotech sat down with Jennifer Altomonte, co-founder of the BioEurope Startup Spotlight finalist, Fusix Biotech, who discussed Fusix’s cancer platform technology. November 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 10 Nov 2025 BIO-Europe partnering: Australian biotech companies share their experiences Australian biotechs share lessons from BIO-Europe on building global partnerships and driving growth beyond their domestic market. November 10, 2025 - 9 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
Podcast 7 Nov 2025Next‑generation UTI diagnostics: delivering results in just 35 minutes Llusern’s Lodestar DX aims to improve urinary tract infection diagnostics. It has created a test that detects pathogens in just 35 minutes, no lab required. November 7, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 31 Oct 2025How AI Is revolutionizing synthetic biology and biomanufacturing Today, with Héctor García Martín, scientist Lawrence Berkeley National Laboratory we’ll dive into why biology has proven so hard to engineer, how AI and robotics are changing that. October 31, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 24 Oct 2025Pichia pastoris: the microbial protein expression platform you’re probably underestimating Today we’re diving into the world of expression systems with Iskandar Dib, of Validogen and we’ll explore the remarkable potential of Pichia pastoris. October 24, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Podcast 17 Oct 2025Biotech royalty deals on the rise and here to stay In today’s episode, we welcome Clarke Futch, Chairman and CEO of HealthCare Royalty Partners, or HCRx, with a thirty year track record in biopharma investing. October 17, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 10 Oct 2025 Practical partnering at BIOSPAIN: on the ground with biotech innovators ready to take the next step We were on the ground in Barcelona speaking to biotech companies, university technology transfer offices, and top pharma firms about their experience at BIOSPAIN and their progress towards securing partnerships. October 10, 2025 - 8 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
Podcast 10 Oct 2025Contraline’s ADAM in the clinic: towards a new era of male contraception? In this week’s podcast we talked with Kevin Eisenfrats, CEO of Contraline, about contraception, male contraception. October 10, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More